Evidence map›Paper›PMID 28674435›Full record

ArticleScientific reports2017

E3 ubiquitin ligase Nedd4 inhibits AP-1 activity and TNF-α production through targeting p38α for polyubiquitination and subsequent degradation.

Qingjun Liu, Shihui Zhang, Gan Chen, Hong Zhou

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Synthesis,Journal of enzyme inhibition and medicinal chemistry · 2023
    Article
  6. Article
  7. Article
  8. Article
  9. Observational
  10. Article
  11. Article
  12. Regulation of Krüppel-like factor 8 by the NEDD4 E3 ubiquitin ligase.American journal of translational research · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Qingjun LiuBeijing Institute of Transfusion Medicine, Beijing Key Laboratory of Blood Safety and Supply Technologies, Taiping Road 27, 100850, Beijing, P.R. China. qjliu2003@163.com.ORCID 0000-0002-8923-3921
Shihui ZhangBeijing Institute of Transfusion Medicine, Beijing Key Laboratory of Blood Safety and Supply Technologies, Taiping Road 27, 100850, Beijing, P.R. China.
Gan ChenBeijing Institute of Transfusion Medicine, Beijing Key Laboratory of Blood Safety and Supply Technologies, Taiping Road 27, 100850, Beijing, P.R. China.
Hong ZhouBeijing Institute of Transfusion Medicine, Beijing Key Laboratory of Blood Safety and Supply Technologies, Taiping Road 27, 100850, Beijing, P.R. China. zhouhtt1966@163.com.
Guangzhou Blood Center · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

p38α plays an important role in many inflammatory diseases, such as skin inflammation, endotoxic shock and arthritis. Ubiquitination is a vital posttranslational modification of proteins and plays a crucial regulatory role in inflammatory cells. It has been reported that ubiquitination of Tak1 and TAB1 upstream of p38α can regulate p38α activation respectively. However, p38α ubiquitination is not yet clear. In this paper, we showed that E3 ubiquitin ligase Nedd4 is a regulatory component of the p38α pathway and is responsible for polyubiquitination of p38α through K48-linked and K63-linked polyubiquitination. The levels of p38α and its downstream target TNF-α were increased in Nedd4 deficient macrophages response to LPS compared with wild-type cells. AP-1 activity and degradation of p38α were induced by Nedd4 in a dose-dependent manner. Furthermore, we found that phosphorylation of p38α is involved in the interactions between p38α and Nedd4 and subsequently promotes polyubiquitination of p38α, especially K48-linked polyubiquitination by Nedd4. The different conformation of two p38α isoforms (p38αV1 and p38αV2) might be the cause of their different interactions with Nedd4 and their polyubiquitination sites by Nedd4. Thus, NEDD4 is a previously unknown component of the p38α signaling complex necessary for TNF-α activation.

Indexed as

AnimalsCell Line, TumorGene Knockdown TechniquesHumansLipopolysaccharidesMacrophagesMiceMitogen-Activated Protein Kinase 14Models, MolecularNedd4 Ubiquitin Protein LigasesPhosphorylationProtein ConformationProtein DomainsProteolysisTranscription Factor AP-1Tumor Necrosis Factor-alphaLipopolysaccharidesMitogen-Activated Protein Kinase 14Nedd4 protein, humanNedd4 Ubiquitin Protein LigasesTranscription Factor AP-1Tumor Necrosis Factor-alpha

Identifiers

PMID28674435
PMCPMC5495757
OpenAlexW2725960392

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.